The Future of Engineered Tissue
Frontier Bio has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Frontier Bio's investors include National Science Foundation, Alchemist Accelerator, SkyDeck Berkeley, Brinc, Artesian VC.
Frontier Bio is headquartered in Hayward, United States.
The Future of Engineered Tissue
Frontier Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Frontier Bio — Funding & Investors." VCBacked, December 25, 2024, https://www.vcbacked.co/company/frontier-bio. Accessed September 15, 2026.
VCBacked. (2024). Frontier Bio — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/frontier-bio
{{cite web |title=Frontier Bio — Funding & Investors |url=https://www.vcbacked.co/company/frontier-bio |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated